Dr Harding on the Rationale for Targeting FGFR2 in Cholangiocarcinoma and Biliary Tract Cancer

Tonton & Download Video Musik Gratis

🏠 Beranda
⬇ DOWNLOAD NOW
Kalau muncul iklan pop-up, tutup lalu klik tombol kembali

Download lagu Dr Harding on the Rationale for Targeting FGFR2 in Cholangiocarcinoma and Biliary Tract Cancer secara gratis hanya untuk keperluan promosi. Dukung artis favorit kamu dengan membeli musik original di iTunes atau platform resmi lainnya.

🎬 Download Lagu Lainnya

Webinar: Targeting the FGFR pathway: Infigratinib in cholangiocarcinoma Webinar: Targeting the FGFR pathway: Infigratinib in cholangiocarcinoma
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer
FGFR Inhibitors FGFR Inhibitors
Advances in FGFR inhibition for hepatobiliary cancer Advances in FGFR inhibition for hepatobiliary cancer
CCF Webinar: A clinical trial for a potential new tHER2apy for biliary tract cancers CCF Webinar: A clinical trial for a potential new tHER2apy for biliary tract cancers
Management of biliary tract cancers with targeted therapies Management of biliary tract cancers with targeted therapies
Advanced Cholangiocarcinoma: FGFR2 Inhibitors vs Chemo Advanced Cholangiocarcinoma: FGFR2 Inhibitors vs Chemo
Embracing the Era of Individualized Therapy in Advanced Biliary Cancers Embracing the Era of Individualized Therapy in Advanced Biliary Cancers